Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 484 shares at $345.51 ($167K) on 2023-08-09, disclosed to the SEC on 2023-08-11.
Scheduled sale ($167k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $345.51 | 242 | $84K | 50.0% |
| 2 | $345.51 | 242 | $84K | 50.0% |
| Total | $345.51 avg | 484 | $167K | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |